Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Notes Payables (2016 - 2017)

Historic Notes Payables for Sanara MedTech (SMTI) over the last 7 years, with Q4 2017 value amounting to $1.2 million.

  • Sanara MedTech's Notes Payables rose 18961.86% to $1.2 million in Q4 2017 from the same period last year, while for Dec 2017 it was $1.2 million, marking a year-over-year increase of 18961.86%. This contributed to the annual value of $1.2 million for FY2017, which is 18961.86% up from last year.
  • According to the latest figures from Q4 2017, Sanara MedTech's Notes Payables is $1.2 million, which was up 18961.86% from $1.2 million recorded in Q3 2017.
  • In the past 5 years, Sanara MedTech's Notes Payables registered a high of $2.3 million during Q2 2013, and its lowest value of $223500.0 during Q2 2017.
  • In the last 4 years, Sanara MedTech's Notes Payables had a median value of $528800.0 in 2015 and averaged $942534.2.
  • Data for Sanara MedTech's Notes Payables shows a peak YoY increase of 18961.86% (in 2017) and a maximum YoY decrease of 4953.71% (in 2017) over the last 5 years.
  • Over the past 4 years, Sanara MedTech's Notes Payables (Quarter) stood at $2.3 million in 2013, then crashed by 73.35% to $614700.0 in 2015, then tumbled by 32.6% to $414338.0 in 2016, then soared by 189.62% to $1.2 million in 2017.
  • Its Notes Payables stands at $1.2 million for Q4 2017, versus $1.2 million for Q3 2017 and $223500.0 for Q2 2017.